Cargando…
Prioritizing risk genes as novel stratification biomarkers for acute monocytic leukemia by integrative analysis
Acute myeloid leukemia (AML) is a blood cancer with high heterogeneity and stratified as M0–M7 subtypes in the French-American-British (FAB) diagnosis system. Improved diagnosis with leverage of key molecular inputs will assist precisive medicine. Through deep-analyzing the transcriptomic data and m...
Autores principales: | He, Hang, Wang, Zhiqin, Yu, Hanzhi, Zhang, Guorong, Wen, Yuchen, Cai, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247126/ https://www.ncbi.nlm.nih.gov/pubmed/35771283 http://dx.doi.org/10.1007/s12672-022-00516-y |
Ejemplares similares
-
Correction to: Prioritizing risk genes as novel stratification biomarkers for acute monocytic leukemia by integrative analysis
por: He, Hang, et al.
Publicado: (2022) -
Prognostic stratification of molecularly and clinically distinct subgroup in children with acute monocytic leukemia
por: Liu, Li‐Peng, et al.
Publicado: (2020) -
Integrated analysis of microRNA and transcription factors in the bone marrow of patients with acute monocytic leukemia
por: Lin, Xiao-Cong, et al.
Publicado: (2021) -
Novel agents and biomarkers for acute lymphoid leukemia
por: Zhao, Yanmin, et al.
Publicado: (2013) -
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors
por: Boscaro, Eleonora, et al.
Publicado: (2023)